Mauna Kea Technologies Share Price

Equities

ALMKT

FR0010609263

Advanced Medical Equipment & Technology

Real-time Euronext Paris 11:45:08 22/07/2024 BST 5-day change 1st Jan Change
0.41 EUR +3.40% Intraday chart for Mauna Kea Technologies +5.81% -12.95%

Financials

Sales 2024 * 7.14M 7.77M 601M Sales 2025 * 8.21M 8.94M 691M Capitalization 25.63M 27.91M 2.16B
Net income 2024 * -9M -9.8M -758M Net income 2025 * -8M -8.71M -674M EV / Sales 2024 * 8.75 x
Net Debt 2024 * 36.86M 40.14M 3.1B Net Debt 2025 * 45.2M 49.22M 3.81B EV / Sales 2025 * 8.63 x
P/E ratio 2024 *
-2.2 x
P/E ratio 2025 *
-2.33 x
Employees 68
Yield 2024 *
-
Yield 2025 *
-
Free-Float 66.98%
More Fundamentals * Estimated data
Dynamic Chart
1 day+3.40%
1 week+5.81%
Current month+8.90%
1 month+6.22%
3 months+5.67%
6 months-8.99%
Current year-12.95%
More quotes
1 week
0.38
Extreme 0.381
0.44
1 month
0.37
Extreme 0.37
0.44
Current year
0.34
Extreme 0.3415
0.52
1 year
0.34
Extreme 0.3415
0.65
3 years
0.34
Extreme 0.3415
1.33
5 years
0.34
Extreme 0.3415
2.00
10 years
0.34
Extreme 0.3415
7.24
More quotes
Managers TitleAgeSince
Chief Executive Officer - 30/04/00
Director of Finance/CFO - 12/06/23
Chief Operating Officer - -
Members of the board TitleAgeSince
Director/Board Member - 31/12/07
Chief Executive Officer - 30/04/00
Director/Board Member 60 14/01/18
More insiders
Date Price Change Volume
22/07/24 0.41 +3.40% 1 194 079
19/07/24 0.3965 +0.38% 264,572
18/07/24 0.395 +1.28% 476,931
17/07/24 0.39 -0.76% 109,149
16/07/24 0.393 +1.42% 292,216

Real-time Euronext Paris, July 22, 2024 at 11:45 am

More quotes
Mauna Kea Technologies specializes in designing, developing, and selling optical biopsy devices and tools. The group's products are intended for visualizing and detecting cellular abnormalities during the gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. Net sales break down by activity as follows: - sale of licenses (40.7%); - sales of accessories (37.3%): mini-probes, software, etc.; - sales of system (11.2%); - services (10.8%). Net sales are distributed geographically as follows: Europe/Middle East/Africa (15.5%), the United States and Canada (42.9%) and Asia (41.6%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.3965 EUR
Average target price
2 EUR
Spread / Average Target
+404.41%
Consensus

Quarterly revenue - Rate of surprise